Assessment of BRAF Mutations Status in 320 Moroccan Colorectal Cancer Patients and Its Correlation with Clinico-Pathological Characteristics: The Largest North African Case Series

Introduction: This study investigates the BRAF mutations as a biomarker for colorectal cancer (CRC) in Moroccan population. Given limited data on BRAF, particularly in low- and middle-income countries, the study aims to address this lack of epidemiological data by carefully examining its frequency and correlations with clinicopathological features in Moroccan CRC patients. The research contributes to providing insights to enhance diagnostic and therapeutic strategies.